Serial 97269790
Live / Registered — Registered (as of 12 Mar 2024)
What this means for you
Registered since 12 Mar 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97269790
- Registration number
- 7328486
- Mark type
- Design / logo
- Filed
- 16 Feb 2022
- Published for opposition
- 01 Nov 2022
- Registered
- 12 Mar 2024
- Attorney of record
- Danielle R. Weitzman
Goods and services
- Class 005 — Pharmaceuticals: Human pharmaceuticals for the treatment of prostate cancer
Owner
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
- Johnson & Johnson, New Brunswick, NJ, US
Prosecution history
- 12 Mar 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Mar 2024 — REGISTERED-PRINCIPAL REGISTER
- 09 Feb 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Feb 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 11 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jan 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jan 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Jan 2024 — NON-FINAL ACTION E-MAILED
- 09 Jan 2024 — SU - NON-FINAL ACTION - WRITTEN
- 13 Dec 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 01 Dec 2023 — USE AMENDMENT FILED
- 11 Dec 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 01 Dec 2023 — TEAS STATEMENT OF USE RECEIVED
- 06 Jun 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED